Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment-Reference-Cited by-同舟云学术

Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment

Published:2014-04-15 Issue:2 Volume:46 Page:172-177
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Lee Jung Hyun,Kang Sung Gu,Kim Seung Tae,Kang Seok Ho,Choi In Keun,Park Young Je,Oh Sang Chul,Sung Deuk Jae,Seo Jae Hong,Cheon Jun,Shin Sang Won,Kim Yeul Hong,Kim Jun Suk,Park Kyong Hwa

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-46-172.pdf

Reference23 articles.

1. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

2. Advanced bladder and urothelial cancers

3. The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer

4. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Systemic chemotherapy in inoperable or metastatic bladder cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis;International Journal of Clinical Oncology;2021-10-11

2. SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer;World Journal of Urology;2018-09-20

3. Efficacy of Different Second-line Therapy Regimens in Metastatic Urothelial Carcinoma;The Open Urology & Nephrology Journal;2017-12-18

4. Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin;Clinical Genitourinary Cancer;2016-08

5. Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis;OncoTargets and Therapy;2016-03